Medicus Pharma Ltd. (MDCXW) Total Return Calculator with Dividends Reinvested

Medicus Pharma Ltd.

Popular:

The total return for Medicus Pharma Ltd. (MDCXW) stock is -46.24% over the past 12 months. So far it's down 82.80% this year. The 5-year total return is -28.27%, meaning $10,000 invested in MDCXW stock 5 years ago would be worth $7,173 today. Total return includes price appreciation plus reinvesting any dividends paid out.

If you invested $10,000 in MDCXW 1 year ago, it would be worth $5,603 today — you'd have lost $4,397.

With Dividends Reinvested$5,603-43.97%

Price Only (No DRIP)$5,603-43.97%

Period2025-06-30 → 2026-06-25

Price

Total Return (DRIP)

S&P 500

If You Invested $10,000 in MDCXW

1Y$5,376-$4,624 (-46.2%)-46.2% CAGR

3Y$7,173-$2,827 (-28.3%)-10.5% CAGR

5Y$7,173-$2,827 (-28.3%)-6.4% CAGR

10Y$7,173-$2,827 (-28.3%)-3.3% CAGR

15Y$7,173-$2,827 (-28.3%)-2.2% CAGR

20Y$7,173-$2,827 (-28.3%)-1.6% CAGR

30Y$7,173-$2,827 (-28.3%)-1.1% CAGR

Medicus Pharma Ltd. did not pay dividends during this period. Total return = price return.

Loading MDCXW total return...

As of 2026-06-29

Performance Summary

Best Year+194.12%2025

Worst Year+45.40%2024

Max Drawdown-88.80%2026-02-24 → 2026-04-21

Period	Total Return	CAGR	Price Only	Div. Contrib.	$10K →
YTD	-82.80%	—	-80.20%	—	$1,720
1Y	-46.24%	-46.24%	-47.75%	+1.51 pp	$5,376
3Y	-28.27%	-10.49%	-17.43%	—	$7,173
5Y	-28.27%	-6.43%	-17.43%	—	$7,173
10Y	-28.27%	-3.27%	-17.43%	—	$7,173
15Y	-28.27%	-2.19%	-17.43%	—	$7,173
20Y	-28.27%	-1.65%	-17.43%	—	$7,173
30Y	-28.27%	-1.10%	-17.43%	—	$7,173

Annual Returns

Year	Total Return	Price Return	Div.	S&P 500	vs S&P
2026YTD	-72.00%	-72.00%	—	+0.41%	-72.4pp
2025	+194.12%	+194.12%	—	+16.64%	+177.5pp
2024	+45.40%	+45.40%	—	+24.00%	+21.4pp

MDCXW underperformed the S&P 500 by 67.08pp over the past year (-46.24% vs +20.84%).

Loading summary...

MDCXW Peers' Total Return

Accurate peer set · 10 comparable names

Name	Mkt Cap	30D Rtn	YTD Total Rtn	1Y Total Rtn	Div Contrib	3Y Total Rtn	5Y Total Rtn	10Y Total Rtn
MDCXWMedicus Pharma Ltd.	$11M	+54.6%	-82.8%	-46.2%	—	-28.3%	-28.3%	-28.3%
SNDXSyndax Pharmaceuticals, Inc.	$1.9B	+7.1%	-6.2%	+116.7%	—	-4.9%	+10.1%	+87.4%
TGTXTG Therapeutics, Inc.	$8.5B	+40.5%	+83.1%	+43.7%	—	+134.4%	+38.1%	+785.9%
CRVSCorvus Pharmaceuticals, Inc.	$1.1B	+5.1%	+76.9%	+198.4%	—	+528.6%	+360.9%	-2.6%
IMVTImmunovant, Inc.	$8.0B	+14.8%	+47.5%	+138.9%	—	+98.5%	+247.5%	+284.1%
NKTRNektar Therapeutics	$1.2B	-2.9%	+49.5%	+165.4%	—	+621.1%	-74.6%	-69.9%
ADMAADMA Biologics, Inc.	$2.0B	+7.4%	-51.3%	-51.3%	—	+129.6%	+427.3%	+25.5%
AGENAgenus Inc.	$126M	-8.7%	-9.6%	-41.6%	—	-91.1%	-97.3%	-96.3%
CLDXCelldex Therapeutics, Inc.	$2.3B	+14.3%	+25.1%	+56.0%	—	-4.4%	+5.6%	-48.3%
HALOHalozyme Therapeutics, Inc.	$8.9B	+9.1%	+1.2%	+32.0%	—	+104.2%	+56.2%	+743.0%
CRLCharles River Laboratories International, Inc.	$10.4B	+37.7%	-0.2%	+36.2%	—	-2.0%	-44.9%	+151.5%

Compare:MDCXW vs SNDX MDCXW vs TGTX MDCXW vs CRVS MDCXW vs SNDX vs TGTX

About MDCXW Dividend Returns

Medicus Pharma Ltd. (MDCXW) does not currently pay dividends. Many growth-focused companies reinvest profits back into the business rather than distributing them as dividends.

How We Calculate Total Return

Our total return calculator simulates dividend reinvestment (DRIP) by assuming each dividend payment is used to purchase additional shares at the closing price on the ex-dividend date. This methodology provides an accurate representation of how a dividend reinvestment plan would perform.

Frequently Asked Questions

Q1What is the total return of MDCXW over the past year?

Medicus Pharma Ltd. (MDCXW) delivered a return of -46.24% over the past year. Since MDCXW does not currently pay dividends, the total return equals the price-only return.

Q2How much would $10,000 invested in MDCXW be worth today?

A $10,000 investment in Medicus Pharma Ltd. one year ago would be worth $5,376 today, representing a loss of $4,624.

Q3Does MDCXW pay dividends?

Medicus Pharma Ltd. (MDCXW) does not currently pay dividends. Many growth-focused companies reinvest profits back into the business rather than distributing them as dividends. For MDCXW, the total return equals the price-only return.

Q4Did MDCXW beat the S&P 500?

No, Medicus Pharma Ltd. (MDCXW) underperformed the S&P 500 by 67.08 percentage points over the past year. MDCXW delivered a total return of -46.24%, compared to the S&P 500's 20.84%. This means a passive S&P 500 index fund outperformed MDCXW by 67.08pp during this period.

Q5What is MDCXW's worst drawdown?

Medicus Pharma Ltd. (MDCXW) experienced a maximum drawdown of -88.80% over the past year, declining from its peak on 2026-02-24 to its trough on 2026-04-21. The stock has not yet fully recovered to its prior peak. Maximum drawdown measures the worst peak-to-trough decline and is an important risk metric for investors.

Q6What is MDCXW's long-term total return over 10, 20, or 30 years?

Here are Medicus Pharma Ltd. (MDCXW)'s long-term returns with dividends reinvested. Over 10 years, the total return is -28.3% (-3.3% CAGR) — $10,000 would have grown to $7,173. Over 20 years: -28.3% total return (-1.6% CAGR) — $10,000 → $7,173. Over 30 years: -28.3% total return (-1.1% CAGR) — $10,000 → $7,173. Long-term investors benefit from compounding: dividends buy additional shares, which generate their own dividends, creating an exponential growth effect.

Q7What was MDCXW's best and worst year?

Medicus Pharma Ltd.'s best calendar year was 2025 with a total return of 194.1%. Its worst year was 2024 with a total return of 45.4%. This range shows the volatility investors should expect — the difference between the best and worst year is 148.7 percentage points.

How much would $100/month in MDCXW be worth today?

Dollar cost averaging calculator · DCA vs lump sum · see how regular investing compounds

Run the Numbers →